1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine

Catalog No. :
ACHQUR213
CAS No. :
1080622-86-1
Molecular Formula :
C17H15N7O2
Molecular Weight :
349.35

IUPAC Name:1-(6,7-dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine

1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg99%$91.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine
IUPAC Name1-(6,7-dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine
MDL No.MFCD17392566
Molecular FormulaC17H15N7O2
Molecular Weight349.35
SMILESNC1=NC(C2=NC=CC=C2)=NN1C3=C4C=C(OC)C(OC)=CC4=NC=N3
InChI KeyILBRKJBKDGCSCB-UHFFFAOYSA-N
Synonym2-(6,7-Dimethoxy-quinazolin-4-yl)-5-pyridin-2-yl-2H-[1,2,4]triazol-3-ylamine | AC-28457 | BCP02229 | A25042 | CP466722, >=98% (HPLC) | HMS3265A19 | HMS3265B20 | CI 60710 | 2-(6,7-dimethoxyquinazolin-4-yl)-5-(pyridin-2-yl)-2H-1,2,4-triazol-3-amine;CP-46672
CAS No.1080622-86-1
PubChem CID44551660

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHQUR213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHQUR213 route product structure diagram
    ACHQUR2131080622-86-1 In Stock
Inquiry

2. ACHQUR213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOJZD165 route compound structure diagram
    ACOJZD165197958-29-5 In Stock
  4. Then
  5. ACHQUR213 route product structure diagram
    ACHQUR2131080622-86-1 In Stock
Inquiry

Comments (0)